Table 2.
Allogeneic stem cell transplant characteristics
| Variable | No (%) |
|---|---|
| Donor used | |
| MRD | 12 (75%) |
| Haploidentical | 4 (25%) |
| Conditioning-MRD (n = 12) | |
| Myeloablative (n = 9) | |
| Cy-TBI-12 Gy | 5 |
| Bu 12.8/kg-Flu | 1 |
| Flu-TBI-12 Gy-PTCy | 3 |
| RIC (n = 3) | |
| Flu-TBI-8Gy-PTCy | 2 |
| Bu 6.4/kg-Flu-rATG | 1 |
| Conditioning-Haplo (n = 4) | |
| RIC (Flu-TBI-8Gy-PTCy) | 1 |
| NMA (Flu-Cy-TBI-2Gy-PTCy) | 3 |
| Acute GVHD | |
| Grade 2 | 2 (14%) |
| Grade 3 | 2 (14%) |
| Grade 4 | 2 (14%) |
| Cumulative episodes of CMV reactivation | 10 |
| Chronic GVHD | n = 7 (50%) |
| Limited | 6 (43%) |
| Extensive | 1 (7%) |